This conference is designed for clinicians, clinical researchers, pharmacists, and well-educated patients with complex medical conditions. It is assumed that the participants will have general knowledge of human physiology and medicine and an interest in using Low Dose Naltrexone.
ME accreditation information
The content of this activity does not relate to any product of a commercial interest as defined by the ACCME, therefore, neither the planners nor the faculty have relevant financial relationships to disclose.
Statement of Accreditation:
MNI Great Lakes ECHO is accredited by the Michigan State Medical Society to provide continuing medical education for clinicians.
AMA Credit Designation Statement:
MNI Great Lakes ECHO designates this live activity for a maximum of 15 AMA PRA Category 1 Credit™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
The ACCME is approved by the board of nurses as an acceptable provider of continuing education for renewal of license.
For all other members of the Healthcare Team:
A certificate of attendance will be provided to all other health care professionals requesting credits in accordance with state licensing boards, specialty societies, or other professional associations.
15 Pharmacy Credits - Jointly provided by LDN Research Trust & CPE Consultants
Must be claimed by 25th June 2024
After completing the LiveStream activity and/or Extra Conference Presentations, the participant should be better able to:
Define the mechanism of action of Low Dose Naltrexone (LDN).Discuss why LDN is different from regular dose naltrexone
Describe the Contraindications to the use of LDN in a patient
Describe the benefits observed in the treatment of patients with LDN
Describe the side effects observed in the treatment of patients with LDN
Describe commonly used adjunctive agents and lifestyle modifications in combination with LDN
The LDN Research Trust would like to invite you to participate in our upcoming LDN Research Trust 2023 LDN Conference.
The conference aims to raise awareness of LDN (Low-Dose Naltrexone) among healthcare professionals and encourage its use in treating a growing number of chronic diseases by highlighting compelling examples and real-world results.
The LDN Research Trust 2023 Conference is a three-day charity event organized by the LDN Research Trust and is the only LDN focused event globally. No other event or organization comes close to matching the global reach of the LDN Research Trust.
Estimated Number of Attendees: 250 in-person, 2,000+ live-stream participants.